Medical Metrics, Inc. Announces Involvement in ReOpen CRS Clinical Trials
HOUSTON, TEXAS, UNITED STATES, May 13, 2024 /EINPresswire.com/ -- Medical Metrics, Inc. (MMI) is proud to have partnered with Optinose® on their chronic rhinosinusitis (CRS) clinical program and congratulates the Optinose® team on receiving U.S. …